Adaptis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAPTIS, and what generic and branded alternatives to ADAPTIS drugs are available?
ADAPTIS has eight approved drugs.
Drugs and US Patents for Adaptis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 208113-005 | May 17, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-007 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-003 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 091182-002 | Feb 3, 2014 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 210652-002 | Oct 1, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-004 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 208113-001 | May 17, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |